03 · What You Need to Know
The Ethical Problem Is Not Persuasiveness by Itself
Recruitment is supposed to attract attention
A recruitment invitation has a communicative purpose. It tells potentially eligible people that a study exists and gives them a reason to consider learning more.
There is nothing inherently unethical about making that communication clear, readable, visually appealing, or interesting. Nor must researchers pretend that their work is unimportant. They can explain the study's purpose, identify the population being sought, describe what participation involves, and accurately state compensation or potential benefits where appropriate.
FDA guidance expressly recognizes direct advertising for research participants as an acceptable recruitment practice. Its concern is not advertising itself, but whether the advertisement becomes unduly coercive or misleading about favorable outcomes and benefits.
The ethical target is therefore not a persuasion-free invitation. It is an invitation whose persuasive force remains compatible with a genuinely voluntary decision about participation.
Accuracy is necessary, but accuracy alone may not be enough
Suppose a study pays participants $200.
A recruitment poster that states “Compensation: $200” may be factually accurate. A poster dominated by an enormous “GET $200!” while the research procedures appear in tiny text communicates the same factual amount but creates a different impression.
FDA guidance specifically instructs IRBs reviewing clinical-study advertising to consider not only the information contained in advertisements but also the mode of communication, including the relative size of type and other visual effects. It also states that advertisements may mention payment but should not emphasize the payment or amount through devices such as larger or bold type.
This illustrates a broader communication principle: presentation affects meaning.
Researchers should therefore ask not only, “Is every sentence technically true?” but also, “What overall impression will a reasonable potential participant receive from this invitation?”
Benefits should not become promises
One of the clearest ethical boundaries concerns potential benefit.
FDA guidance warns against research advertisements that state or imply certainty of favorable outcomes or benefits beyond those described in the consent document and protocol. It also cautions against terminology that makes an investigational product sound like an established treatment of proven value.
Proportionate description
“This study is evaluating an investigational treatment for migraine.”
Misleading implication
“Get the newest treatment for your migraines.”
The second formulation can imply that the intervention is already known to be an effective treatment. That implication conflicts with the uncertainty that often explains why the research is being conducted in the first place.
The same principle applies outside clinical research. Researchers should not promise that participants will improve their mental health, academic performance, professional skills, relationships, or other outcomes unless the study can legitimately support such a claim and the approved materials permit it.
Framing can become unbalanced without containing a false statement
Recruitment messages inevitably select what to emphasize. A poster cannot reproduce an entire protocol.
The ethical concern arises when selective emphasis creates a substantially distorted picture of the decision.
Imagine an invitation that says:
“Help transform education! Join an exciting study and receive $50 for only 30 minutes of your time.”
Nothing in that sentence is necessarily false. But context matters. Does “transform education” imply an impact the individual study cannot reasonably claim? Is the session genuinely only 30 minutes, including all required activities? Is $50 being presented proportionately? Are there procedures or burdens important enough that the advertisement becomes misleading if they are omitted?
There is no universal formula for answering these questions. The appropriate amount of recruitment information depends on the study and applicable review requirements. The central issue is whether selective presentation assists initial consideration or creates an impression that materially misrepresents participation.
Emotional language deserves particular care
Emotion is not automatically unethical either.
A cancer study may naturally matter deeply to people affected by cancer. Research on bereavement, rare diseases, infertility, discrimination, violence, disability, or other personally significant experiences cannot always be described in emotionally sterile language.
Problems arise when emotional appeals are used to make refusal morally uncomfortable.
Compare an invitation explaining that a study may contribute to knowledge about a condition with one implying that “people like you are counting on you to participate.” The latter introduces a moral burden into the decision. Similarly, telling students to “support your professor's research” changes the invitation from consideration of a study into a request for personal loyalty.
Researchers should be especially cautious when appeals to altruism, solidarity, duty, gratitude, loyalty, or guilt are directed toward people already connected to the researcher or institution.
Urgency can inform or pressure
Sometimes recruitment genuinely has a deadline. A study may have a defined enrollment period, an intervention may need to begin at a particular point, or a time-sensitive event may determine eligibility.
Researchers may communicate real deadlines.
Artificial urgency is different. “SIGN UP NOW BEFORE YOU MISS OUT!” borrows a familiar commercial technique that may be poorly suited to a decision requiring considered consent. Even genuine urgency should not deprive potential participants of sufficient opportunity to decide.
HHS informed-consent requirements emphasize that prospective participants must have sufficient opportunity to consider participation under circumstances minimizing coercion or undue influence. Recruitment should not undermine that protection before the formal consent conversation even begins.
Social proof can create pressure
Commercial advertising often tells people that thousands of others have already bought a product. Research recruitment may be tempted to use similar techniques.
Statements such as “Everyone in your class is participating,” “Most of your colleagues have already joined,” or “Your friends have signed up” may affect the decision through conformity rather than information about the research itself.
This becomes particularly sensitive where potential participants are embedded in groups with authority structures or strong social relationships. OHRP has noted, for example, that students may experience pressure when everyone else in a class participates.
Even when such statements are factually correct, researchers should ask why the information is being communicated and whether it helps someone understand the research or instead makes refusal socially costly.
Personalization can make an invitation stronger than researchers realize
“We are looking for adults aged 18 to 25” is different from “I specifically need you for my research.”
Personal invitations can be appropriate, especially when recruitment depends on specialized expertise or narrowly defined eligibility. Yet personalization can also imply obligation, particularly when the invitation comes from a teacher, supervisor, clinician, colleague, family member, or another person whose relationship matters to the recipient.
The wording cannot be evaluated independently from the relationship. Researchers should consider whether the power difference surrounding an invitation changes what the words communicate.
Compensation should be visible without becoming the entire proposition
Potential participants should not have to hunt for information about legitimate compensation. Payment may be relevant to deciding whether a study is worth their time.
But recruitment should not turn research into something that looks primarily like a cash promotion.
FDA guidance permits advertisements for clinical investigations to state that participants will be paid but cautions against emphasizing the payment or amount through larger or bold type. The concern is especially understandable when prominent payment could distract from the fact that the advertisement concerns research rather than ordinary employment or a commercial offer.
Payment itself should not automatically be called coercion. The more precise question is whether an incentive or its presentation may constitute undue influence rather than ordinary persuasion in the circumstances.
The ethical test applies to design as well as words
Recruitment increasingly occurs through websites, social media, videos, messaging apps, email, and digital advertising. Ethical review therefore cannot stop at proofreading the script.
Typography, imagery, animation, music, testimonials, button labels, repeated notifications, countdown timers, placement of compensation, and the relative prominence of benefits and burdens can all affect the invitation's overall meaning.
FDA's longstanding requirement that IRBs consider visual effects in clinical-trial advertising captures an important principle that extends beyond printed posters: communication design is part of communication.
Watch Out
A recruitment message can avoid false statements yet still create a misleading overall impression. Evaluate the invitation as potential participants will encounter it, not merely as a collection of individually defensible sentences.